RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1991; 66(06): 741
DOI: 10.1055/s-0038-1646497
DOI: 10.1055/s-0038-1646497
Letter to the Editor
Prothrombin Fragment 1+2 and Intensity of Treatment with Oral Anticoagulants
Weitere Informationen
Publikationsverlauf
Received 10. April 1991
Accepted 27. Mai 1991
Publikationsdatum:
26. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199106/lookinside/thumbnails/10-1055-s-0038-1646497-1.jpg)
-
References
- 1 Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemostas 1991; 65: 153-9
- 2 Aronson DL, Stevan L, Ball AP, Franza Jr BR, Finlayson JS. Generation of the combined prothrombin activation peptide (F1.2) during the clotting of blood and plasma. J Clin Invest 1977; 60: 1410-8
- 3 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotie state in humans: insights gained from studies using markers of the hemostatic system activation. Blood 1987; 70: 343-50
- 4 Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-97
- 5 Conway EM, Bauer KA, Barzegar S, Rosenberg RD. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 1989; 80: 1535-44